The Significance of Cutaneous Allodynia in a Woman With Chronic Pelvic Pain

John Jarrell, Lamia Malekzadeh, Hua Yang, Lars Arendt-Nielsen, Lars Arendt‐Nielsen
Journal of Obstetrics and Gynaecology Canada · 2015 · vol. 37(7) , pp. 628–632 · doi:10.1016/s1701-2163(15)30201-2 · PMID:26366820 · W1872829635
Case report OA: bronze CC0 ⤵ 6 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This case study explored the presence and impact of cutaneous allodynia in a woman experiencing chronic pelvic pain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: This is a case report of sensory assessment in a woman with severe chronic pelvic pain following uterine artery embolization, and a discussion of a commonly observed sensory manifestation (allodynia) associated with chronic pelvic pain due to gynaecological conditions. Allodynia, as a common sensory abnormality can be readily detected at the bedside and represents the development of pain sensitization. Emergence of abdominal and perineal allodynia (assessed by cotton swap stroking and/or questionnaire) is associated with the development of the clinical features of sensitization: continuous pelvic pain, muscle tenderness, and reduced pressure pain thresholds. CASE: A uterine artery embolization was performed on a 42-year-old woman to treat a postpartum hemorrhage. The woman experienced severe pain immediately following the procedure, and it had persisted for one year when she was referred for chronic unrelenting pain. She was found to have extensive allodynia, myofascial dysfunction, and reduced pain thresholds. A hysterectomy was undertaken. As the pain persisted, botulinum toxin was administered to the lower abdomen in the region of reduced pain thresholds. Partial resolution of pain, physical limitation, and allodynia resolved one year after the hysterectomy and shortly after the injections of four tender regions of the anterior cutaneous nerves with 2.5 and 5.0 IU of botulinum toxin. CONCLUSION: Testing for allodynia is a validated bedside test for pain sensitization. A clinical trial of botulinum toxin is indicated for the management of chronic pelvic pain associated with allodynia and pain sensitization.

My notes (saved in your browser only)

Condition tags

chronic_pelvic_pain

MeSH descriptors

Acetylcholine Release Inhibitors Botulinum Toxins Chronic Pain Hyperalgesia Pelvic Pain Uterine Artery Embolization Abdominal Wall Acetylcholine Release Inhibitors Adult Botulinum Toxins Chronic Pain Chronic Pain Chronic Pain Female Humans Hyperalgesia Hyperalgesia Hyperalgesia Hysterectomy Pelvic Pain

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (16)

Cited by (7)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:16:21.477467+00:00
License: CC0 · commercial use OK